lozenge with integral applicator
Consumer Medicine Information (CMI)
What is in this leaflet
This leaflet answers some common questions about Actiq. It does not contain all of
the available information. It does not take the place of talking to your doctor or
All medicines have risks and benefits. Your doctor has weighed the risks of your taking
Actiq against the benefits they expect it will have for you.
If you have any concerns about taking Actiq, talk to your doctor or pharmacist.
Keep this leaflet with the medicine.
You may want to read it again.
What Actiq is used for
Actiq contains a medicine called fentanyl citrate. Fentanyl is a strong pain-relieving
medicine and belongs to a group of medicine known as opioids.
Actiq lozenge with integral applicator is a system for delivering fentanyl directly
through the lining of the mouth. When you place Actiq in your mouth, it dissolves
and the medicine is absorbed through the lining of your mouth, into the blood system.
Taking the medicine in this way allows it to be absorbed very quickly to relieve your
Breakthrough pain is additional sudden pain that occurs in spite of you having taken
your usual opioid pain-relieving medicines.
Keep using the opioid pain medicine you take for your persistent (around-the-clock)
cancer pain during your Actiq treatment.
Opioid medicines are those that contain active ingredients such as morphine, fentanyl
citrate, codeine, methadone, oxycodone, pethidine or buprenorphine.
The use of Actiq by people who are not taking prescription opioid medicines on a regular
basis could result in life-threatening side effects.
Ask your doctor if you have any questions about why Actiq lozenges have been prescribed
Your doctor may have prescribed it for another use.
Medicines like Actiq can lead to addiction. This is unlikely when Actiq is used correctly.
Actiq is only available on a doctor's prescription.
Before you take it
Actiq is not suitable for everyone.
When you must not take it
Do not take Actiq if:
you have short term pain, including pain from injuries, from doctors or dentists visits,
surgery or headaches/migraines
you have not been using a prescribed opioid pain medicine every day on a regular schedule,
for at least one week, to control your persistent pain. This may increase the risk
that your breathing could slow down to a dangerous level, or even stop
you are allergic to fentanyl, or any of the other ingredients in the formulation (see
list at the end of this leaflet)
you are pregnant or breastfeeding, unless your doctor tells you it is safe.
Do not take Actiq after the expiry date shown on the blister package label and the
The unit is normally white however, a slightly mottled appearance may occur on storage.
This is due to slight changes in the flavouring of the product and does not affect
how the product works in any way.
Do not take Actiq if the packaging seems to have been opened.
If you become pregnant whilst taking Actiq, you should stop taking it and see your
Young women taking Actiq and who are at risk of becoming pregnant should make sure
that they are using adequate contraception.
Before you start to take it
Tell your doctor if:
you have any allergies
you are pregnant or intend to become pregnant
you are breast feeding or planning to breast feed
your other opioid pain medicine you take for your persistent (around-the-clock) cancer
pain is not stabilized yet
you have or have had any of the following medical conditions:
chronic diseases of the lung, or other condition which has an effect on your breathing
exceptionally slow heart rate
liver or kidney disease.
These organs have an effect on the way in which your system breaks down the medicine.
Taking other medicines
Tell your doctor if you are taking any other medicines, including any that you buy
without a prescription from your pharmacy, supermarket or health food store.
Take special care with Actiq if:
you are taking any medicines which might normally have a sedative effect (make you
sleepy), such as:
medicines to treat anxiety
you are taking any medicines or other substances that might have an effect on the
way in which your body breaks down Actiq, such as:
drugs used to treat fungal infections
Antidepressants of the serotonergic type. Taking Actiq with these may increase the
risk of serotonergic syndrome, a potentially life threatening condition
you intend to drink alcohol, drive, or operate machinery in the few hours after taking
Actiq. Your doctor will be able to advise you on this.
How to take it
Do not take Actiq to treat any condition other than that directed by your doctor.
How many to take
Your doctor will advise you on the appropriate starting dose of Actiq for the relief
of your breakthrough pain.
Ask your doctor if you are not sure about the right dose or if you have any questions
about taking Actiq.
It is very important that you use this medicine in the manner as directed by your
You should start to feel some pain relief quickly while you are taking Actiq.
Until the dose that effectively controls your breakthrough pain has been determined,
if you do not get enough pain relief from just one Actiq, your doctor may allow you
to use a second dose to treat an episode of breakthrough pain.
Do not use a second Actiq unit unless your doctor tells you to do so and never use
more than two Actiq units to treat a single episode of breakthrough pain.
It is recommended that you wait at least 4 hours before treating another episode of
breakthrough pain with Actiq.
You must tell your doctor immediately if you are using Actiq more than four times
per day, as the doctor may wish to change your medicine for your persistent pain.
Once your persistent pain has been controlled, your doctor may need to change your
dose of Actiq further.
For best results, let your doctor know about your pain and how Actiq is working for
you so that the dose can be changed if needed.
Do not change doses of Actiq or your other pain medicines on your own.
Contact your doctor if your right dose of Actiq does not relieve your breakthrough
pain. Your doctor will decide if your dose needs to be changed.
DO NOT TAKE MORE THAN THE DOSE YOUR DOCTOR HAS RECOMMENDED.
Change in dosage must be directed and monitored by your doctor.
How to take it
1. Each Actiq unit is sealed in its own blister package.
Do not open the package until you are ready to use it.
Hold the blister package with the printed side away from you. Grasp the short tab
end of the blister package. Place scissors close to the end of the Actiq unit and
cut the long tab end completely off (as shown). Separate the printed backing from
the blister package and pull the printed backing completely off the blister package.
Remove the Actiq unit from the blister package.
2. Place Actiq in your mouth between your cheeks and gums. Using the handle, move it
around in your mouth especially along your cheeks. Twirl the handle often.
You may drink some water before using Actiq, to help with taking the product but you
should not drink or eat anything while using Actiq.
3. To get the most effective relief, finish the Actiq completely in 15 minutes. If you
finish it too quickly, you will swallow more of the medicine and get less relief of
your breakthrough pain.
It is also most important that you do not bite or chew Actiq for the same reason.
4. If you begin to feel dizzy or sick before you have finished the medicine, remove the
Actiq unit from your mouth and dispose of it immediately, as instructed in this leaflet.
If for some reason you are not finishing the entire Actiq unit each time you have
an episode of breakthrough pain, you should call your doctor.
5. Once a dose has been arrived at which effectively controls your pain, you should not
use more than four units of Actiq per day. If you think you might need to use more
than four Actiq units per day, you should notify your doctor immediately.
6. Do not use more than two Actiq units to treat a single episode of breakthrough pain.
Taking Actiq with food or drink
Actiq may be used before or after but not during meals. You may drink some water before
using Actiq to help moisten your mouth, but you should not drink or eat anything while
taking the medicine.
When to take it
Actiq must only be used for breakthrough pain. Breakthrough pain is additional sudden
pain that occurs in spite of you having taken your usual opioid pain-relieving medicines.
How long to take it
You should not normally stop taking Actiq for breakthrough pain unless your doctor
tells you to.
If you are taking high doses of Actiq and feel that the pain is getting worse with
time please speak to your doctor.
Tell your doctor if you feel unwell during your course of treatment.
On the advice of your doctor, you may stop taking Actiq if you are no longer experiencing
breakthrough pain. There are usually no noticeable effects if you stop taking Actiq.
You should continue to take your usual opioid medicine to treat your persistent (around-the-clock)
pain as instructed by your doctor.
How to dispose of Actiq after use
Partially used Actiq units may contain enough medicine to be harmful or life-threatening
to a child.
Even if there is little or no medicine left on the handle, the handle itself must
be properly disposed of, as follows:
If the medicine is totally gone, throw the handle away in a waste container that is
out of reach of children and pets.
If any medicine remains on the handle, place the unit under hot running water to dissolve
the remainder and then throw the handle away in a waste container that is out of reach
of children and pets.
If you do not finish the entire Actiq unit and you cannot immediately dissolve the
remaining medicine, put the Actiq unit out of reach of children and pets until such
a time as you can dispose of the partially used Actiq unit as instructed above.
Do not flush partially used Actiq units, Actiq handles, or the blister packaging down
If you take too many Actiq units (overdose)
Immediately telephone your doctor or the Poisons Information Centre (telephone 13
11 26) for advice, or go to Accident and Emergency at your nearest hospital if you
think that you or anyone else may have taken too many Actiq units.
Do this even if there are no signs of discomfort or poisoning.
The most common side effects are feeling sleepy, sick or dizzy. If you begin to feel
very sleepy, remove the Actiq unit from your mouth and call another person to help
A serious side effect of Actiq is slow shallow breathing. This can occur if your dose
of this medicine is too high or if you take too much Actiq. You and your carer should
discuss this side effect with your doctor.
Note to carers
If you see that the patient taking Actiq has slow breathing or if you have a hard
time waking the person up, take the following steps IMMEDIATELY:
1. Using the handle, remove the Actiq unit from the person's mouth and keep it out of
reach of children or pets until the Actiq unit is disposed of.
2. CALL FOR EMERGENCY HELP.
3. See instructions below for what to do if a child or adult accidentally takes Actiq.
What to do if a child or adult accidentally takes Actiq
If you think someone has accidentally taken Actiq follow these steps:
1. If the person is asleep, wake them up by calling their name and shaking their arm
2. CALL FOR EMERGENCY HELP.
3. While waiting for emergency help:
if the person seems to be breathing slowly, prompt them to breathe every 5-10 seconds
if the person has stopped breathing give mouth to mouth resuscitation until help arrives.
If someone has accidentally taken Actiq, they may have the following symptoms:
itching, especially around the nose and eyes
feeling sick or vomiting
not breathing or breathing very slowly.
While you are taking it
Things you must do
Make sure that all of your doctors and pharmacists know about your use of Actiq. Remind
them if any new medicines are about to be started, including any medicines that you
may purchase without a prescription.
Things that you must not do
Do not use Actiq to treat any other complaints unless your doctor tells you to.
It may not be safe to use Actiq for another complaint.
Do not give Actiq to someone else even if their symptoms are the same.
Actiq should only be used by the person for whom it was prescribed. It may not be
safe for another person to use Actiq.
Tell your doctor or pharmacist as soon as possible if you do not feel well while you
are taking this medicine.
Like all medicines, Actiq can cause side effects. Sometimes they are serious, most
of the time they are not. You may need medical treatment if you get some of the side
Ask your doctor or pharmacist to answer any questions you may have.
Tell your doctor if you notice any of the following and they worry you:
If you feel excessively dizzy, sleepy or otherwise ill while taking Actiq, use the
handle to remove the Actiq unit and dispose of it according to the instructions given
in this leaflet. Then contact your doctor for further directions on using Actiq.
Do not drive or operate machinery if you are feeling sleepy, dizzy or have difficulty
Tell your doctor immediately, or get someone to take you to Accident and Emergency
at your nearest hospital if you notice any of the following:
becoming very sleepy
having slow or shallow breathing
sudden signs of allergy such as rash, itching or hives on the skin, swelling of the
lips, tongue or throat, shortness of breath, wheezing or trouble breathing.
if you have some or all of the following symptoms you may have something called serotonin
syndrome: feeling confused, feeling restless, sweating, shaking, shivering, hallucinations,
sudden jerks in your muscles or a fast heart beat
Whilst using the Actiq lozenge you may experience irritation, pain, gum bleeding or
an ulcer at the site of application.
Tell your doctor if you notice anything else that is making you feel unwell.
Other side effects not listed in this leaflet may also occur in some patients.
Do not be alarmed by this list of possible side effects.
You may not experience any of them.
After using it
Keep Actiq lozenges in their individual blister package and carton box until it is
time to take the dose.
If you take Actiq out of its blister package, it may not keep as well.
Do not use it if the blister package has been damaged or opened before you are ready
to use it.
Keep Actiq in a cool dry place where the temperature stays below 30°C.
Do not store it or any other medicine in the bathroom or near a sink. Do not leave
it in the car on hot or cold days.
Heat, cold and dampness can destroy some medicines.
Actiq lozenges must be kept out of the reach of children.
The pain-relieving medicine in Actiq is very strong and could be life-threatening
if taken accidentally by a child.
A locked cupboard at least one- and-a-half metres above the ground is a good place
to store medicines.
Return all unused units to the pharmacist or doctor if you are no longer using Actiq
or if you have unwanted units.
What Actiq looks like
The Actiq unit consists of a white to off-white solid medication attached to a handle
Each unit contains either 200 micrograms, 400 micrograms, 600 micrograms, 800 micrograms,
1200 micrograms or 1600 micrograms of the active ingredient fentanyl.
The dosage strength is marked on the medication, on the handle and on the blister
package to ensure that you are taking the right medicine.
Each blister package contains one individual Actiq unit.
The active ingredient is fentanyl, present in the product as fentanyl citrate.
Dextrates, citric acid, dibasic sodium phosphate, artificial berry flavour (maltodextrin,
propylene glycol, artificial flavours, and triethyl citrate), magnesium stearate,
confectioner's sugar (as sucrose and maize starch), purified water, and starch sodium
octenyl succinate (E1450). The imprinting ink used contains de-waxed white shellac
and brilliant blue FCF CI42090.
Each unit of Actiq provides approximately 2 grams of glucose load from the dextrates.
Actiq is supplied in Australia by:
Teva Pharma Australia Pty Ltd
37 Epping Rd.
Telephone: 1800 288 382
Australian Registration Numbers:
Actiq 200 micrograms: AUST R 91598
Actiq 400 micrograms: AUST R 91600
Actiq 600 micrograms: AUST R 91601
Actiq 800 micrograms: AUST R 91602
Actiq 1200 micrograms: AUST R 91603
Actiq 1600 micrograms: AUST R 91604.
ACTIQ is a registered trademark of Teva Pharmaceutical Industries Limited
This leaflet was revised in August 2017.